Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	62.14	54.3	89.14	60.08	127.68	59.25
Short-Term Investments	278.49	334.65	231.43	215.77	205.61	235.61
Cash & Short-Term Investments	340.63	388.95	320.57	275.85	333.29	294.86
Cash Growth	8.31%	21.33%	16.21%	-17.23%	13.04%	70.64%
Accounts Receivable	34.19	26.08	18.51	14.87	6.22	1.03
Inventory	28.65	25.75	18.74	8.62	2.92	0.11
Other Current Assets	26.62	26.13	16.38	8.93	11.81	12.4
Total Current Assets	430.09	466.92	374.2	308.27	354.24	308.39
Net Property, Plant & Equipment	4	4.15	4.11	2.12	3.38	4.34
Other Intangible Assets	5.11	5.32	6.17	7.03	7.88	4.66
Other Long-Term Assets	3.12	3.81	7.79	15.33	16.98	12.14
Total Assets	442.32	480.2	392.27	332.75	382.48	329.52
Accounts Payable	12.3	13.95	12.33	4.89	4.8	5.74
Accrued Expenses	80.05	83.86	62.66	48.26	32.89	30.08
Current Portion of Leases	0.68	0.65	-	0.77	0.68	0.61
Unearned Revenue	0.05	0.19	1.29	1.29	1.43	7
Other Current Liabilities	10.13	7.3	39.25	-	-	-
Total Current Liabilities	103.2	105.94	115.52	55.2	39.81	43.43
Long-Term Leases	3.16	3.34	3.94	0.49	1.26	1.95
Other Long-Term Liabilities	98.34	100.89	108.27	107.29	77.15	-
Total Long-Term Liabilities	101.5	104.23	112.21	107.78	78.41	1.95
Total Liabilities	204.7	210.17	227.72	162.99	118.22	45.37
Common Stock	0.07	0.07	0.06	0.06	0.06	0.05
Additional Paid-in Capital	1,530	1,492	1,177	1,064	974.36	813.04
Accumulated Other Comprehensive Income	0.44	-0.8	-0.04	0.13	-0.09	-0
Retained Earnings	-1,408	-1,352	-1,155	-894.74	-710.06	-528.94
Total Common Shareholders' Equity	122.91	139.07	21.73	169.76	264.26	284.15
Minority Interest	114.71	130.96	142.82	-	-	-
Shareholders' Equity	237.62	270.03	164.55	169.76	264.26	284.15
Total Liabilities & Equity	442.32	480.2	392.27	332.75	382.48	329.52
Total Debt	3.84	3.99	3.94	1.26	1.94	2.55
Net Cash (Debt)	336.79	384.96	316.63	274.59	331.34	292.3
Net Cash Growth	-12.51%	21.58%	15.31%	-17.13%	13.36%	72.24%
Net Cash Per Share	5.09	5.92	5.19	4.76	6.36	5.89
Book Value	122.91	139.07	21.73	169.76	264.26	284.15
Book Value Per Share	1.86	2.14	0.36	2.94	5.07	5.73
Tangible Book Value	117.8	133.75	15.56	162.73	256.38	279.49
Tangible Book Value Per Share	1.78	2.06	0.26	2.82	4.92	5.63

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q